482 related articles for article (PubMed ID: 17846116)
1. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.
Dzierszinski F; Pepper M; Stumhofer JS; LaRosa DF; Wilson EH; Turka LA; Halonen SK; Hunter CA; Roos DS
Infect Immun; 2007 Nov; 75(11):5200-9. PubMed ID: 17846116
[TBL] [Abstract][Full Text] [Related]
2. Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii.
Gubbels MJ; Striepen B; Shastri N; Turkoz M; Robey EA
Infect Immun; 2005 Feb; 73(2):703-11. PubMed ID: 15664908
[TBL] [Abstract][Full Text] [Related]
3. Subcellular antigen location influences T-cell activation during acute infection with Toxoplasma gondii.
Gregg B; Dzierszinski F; Tait E; Jordan KA; Hunter CA; Roos DS
PLoS One; 2011; 6(7):e22936. PubMed ID: 21829561
[TBL] [Abstract][Full Text] [Related]
4. The involvement of immunoproteasomes in induction of MHC class I-restricted immunity targeting Toxoplasma SAG1.
Ishii K; Hisaeda H; Duan X; Imai T; Sakai T; Fehling HJ; Murata S; Chiba T; Tanaka K; Hamano S; Sano M; Yano A; Himeno K
Microbes Infect; 2006 Apr; 8(4):1045-53. PubMed ID: 16515877
[TBL] [Abstract][Full Text] [Related]
5. Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection.
Leroux LP; Nishi M; El-Hage S; Fox BA; Bzik DJ; Dzierszinski FS
Infect Immun; 2015 Oct; 83(10):3865-80. PubMed ID: 26195549
[TBL] [Abstract][Full Text] [Related]
6. Antigen presentation by Toxoplasma gondii-infected cells to CD4+ proliferative T cells and CD8+ cytotoxic cells.
Yano A; Aosai F; Ohta M; Hasekura H; Sugane K; Hayashi S
J Parasitol; 1989 Jun; 75(3):411-6. PubMed ID: 2786064
[TBL] [Abstract][Full Text] [Related]
7. Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo.
Bertholet S; Goldszmid R; Morrot A; Debrabant A; Afrin F; Collazo-Custodio C; Houde M; Desjardins M; Sher A; Sacks D
J Immunol; 2006 Sep; 177(6):3525-33. PubMed ID: 16951311
[TBL] [Abstract][Full Text] [Related]
8. Rhoptry and Dense Granule Secreted Effectors Regulate CD8
Rommereim LM; Fox BA; Butler KL; Cantillana V; Taylor GA; Bzik DJ
Front Immunol; 2019; 10():2104. PubMed ID: 31555296
[No Abstract] [Full Text] [Related]
9. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
[TBL] [Abstract][Full Text] [Related]
10. An Unusual MHC Molecule Generates Protective CD8+ T Cell Responses to Chronic Infection.
Tsitsiklis A; Bangs DJ; Lutes LK; Chan SW; Geiger KM; Modzelewski AJ; Labarta-Bajo L; Wang Y; Zuniga EI; Dai S; Robey EA
Front Immunol; 2020; 11():1464. PubMed ID: 32733483
[TBL] [Abstract][Full Text] [Related]
11. MHC I presentation of Toxoplasma gondii immunodominant antigen does not require Sec22b and is regulated by antigen orientation at the vacuole membrane.
Buaillon C; Guerrero NA; Cebrian I; Blanié S; Lopez J; Bassot E; Vasseur V; Santi-Rocca J; Blanchard N
Eur J Immunol; 2017 Jul; 47(7):1160-1170. PubMed ID: 28508576
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.
Hakim FT; Gazzinelli RT; Denkers E; Hieny S; Shearer GM; Sher A
J Immunol; 1991 Oct; 147(7):2310-6. PubMed ID: 1918963
[TBL] [Abstract][Full Text] [Related]
13. A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells.
Santone M; Aprea S; Wu TY; Cooke MP; Mbow ML; Valiante NM; Rush JS; Dougan S; Avalos A; Ploegh H; De Gregorio E; Buonsanti C; D'Oro U
Hum Vaccin Immunother; 2015; 11(8):2038-50. PubMed ID: 26024409
[TBL] [Abstract][Full Text] [Related]
14. Toxoplasma gondii glycosylphosphatidylinositols up-regulate major histocompatibility complex (MHC) molecule expression on primary murine macrophages.
Debierre-Grockiego F; Molitor N; Schwarz RT; Lüder CG
Innate Immun; 2009 Feb; 15(1):25-32. PubMed ID: 19201822
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
Martinez-Kinader B; Lipford GB; Wagner H; Heeg K
Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131
[TBL] [Abstract][Full Text] [Related]
16. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
17. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
[TBL] [Abstract][Full Text] [Related]
18. Transnuclear CD8 T cells specific for the immunodominant epitope Gra6 lower acute-phase Toxoplasma gondii burden.
Sanecka A; Yoshida N; Dougan SK; Jackson J; Shastri N; Ploegh H; Blanchard N; Frickel EM
Immunology; 2016 Nov; 149(3):270-279. PubMed ID: 27377596
[TBL] [Abstract][Full Text] [Related]
19. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.
Denkers EY; Scharton-Kersten T; Barbieri S; Caspar P; Sher A
J Exp Med; 1996 Jul; 184(1):131-9. PubMed ID: 8691126
[TBL] [Abstract][Full Text] [Related]
20. Development of a system to study CD4+-T-cell responses to transgenic ovalbumin-expressing Toxoplasma gondii during toxoplasmosis.
Pepper M; Dzierszinski F; Crawford A; Hunter CA; Roos D
Infect Immun; 2004 Dec; 72(12):7240-6. PubMed ID: 15557649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
